Neurofeedback News
Excellent Brain Partners with Scholas Occurrentes to Bring ADHD Neurofeedback Training to Schools and Universities Worldwide -
Founded in 2015 and based in Israel, Excellent Brain Ltd. develops neurofeedback-based brain-training technology designed to support attention and focus. Its Trainer Kit, is used by clinics, schools, ...
Can Neurofeedback Effectively Treat ADHD? -
Neurofeedback training is an alternative therapy that uses real-time EEG data to help patients train their brains to improve focus, impulse control, and executive function. Since the 1970s, patients ...
What Is Neurofeedback Therapy And How Does It Work? -
Ashwini Nadkarni, M.D., is a board-certified psychiatrist, Assistant Professor at Harvard Medical School and Interim Vice Chair for Faculty Affairs in the Department of Psychiatry at Brigham and Women ...
What Does a Neurofeedback Technician Do? -
Neurofeedback is about helping a client's brain learn to self-regulate by showing it its own EEG activity on a screen or through headphones. It is like going to the gym for your brain. It is not a ...
Novel neurofeedback technique enhances awareness of mind-wandering -
Everyone knows the feeling. You are trying to concentrate on driving or studying, or paying attention in a boring meeting, but suddenly, you realize that you are thinking about something irrelevant to ...
Medical News Today
PubMed
The post-acute phase of new-onset refractory status epilepticus (NORSE) / febrile infection-related epilepsy syndrome (FIRES) -
In this narrative review, we will summarize the existing literature describing long-term outcomes after new-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. Febrile infection-related epilepsy syndrome is more common in children and has been described as a multiphasic presentation with a prodrome, an acute epileptic phase and a chronic epileptic phase. Importa...
Neuromodulation in NORSE/FIRES -
Neuromodulation is emerging as a promising adjunctive strategy for the management of new-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES), conditions characterized by high morbidity, frequent treatment resistance, and a substantial risk of chronic epilepsy. This chapter presents a systematic review of reported neuromodulation interventions in N...
Symptomatic management of NORSE/FIRES: Acute and chronic anti-seizure treatment -
The treatment paradigm in new onset refractory status epilepticus (NORSE) and its subtype febrile infection-related epilepsy syndrome (FIRES) is generally multimodal, including treatments that target the underlying etiology (immunotherapy) and symptomatic treatment of seizures (anti-seizure medications (ASMs), ketogenic diet, and neuromodulation/epilepsy surgery). In the acute phase, treatment ...
Physician-Family communication in new-onset refractory status epilepticus (NORSE): Communicating when there are few answers -
New-Onset Refractory Status Epilepticus (NORSE) and its sub-type, Febrile Infection-Related Epilepsy Syndrome (FIRES) is a profoundly challenging condition due to its rarity, diagnostic and prognostic uncertainty, and outcomes with high morbidity and mortality. While prior research has focused primarily on treatment strategies and outcomes in the acute phase, little attention has been given to ...
Biomarkers of new onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES) -
New Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) present significant diagnostic challenges. To date, no single testing modality has emerged as the standard to confirm or exclude NORSE/FIRES. However, there has been increasing characterization of NORSE/FIRES by magnetic resonance imaging (MRI), electroencephalogram (EEG), and serum and cereb...
The creation of an international NORSE/FIRES virtual consultation forum -
CONCLUSIONS: This international conference model represents a shift toward a collaborative, global expertise framework, effectively "democratizing" specialized knowledge for refractory status epilepticus, especially those possibly caused by rare neuroinflammatory diseases. While currently a descriptive, observational experience lacking patient-level outcome data, the initiative serves as a scal...
Science Daily